Wang et al. analyzed 114 Chinese NSCLC patients, finding higher metastasis in older patients with TP53 mutations, while EGFR, ASXL2, and STK11 mutations correlated with better survival [115]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.